GlassScriptPhysician profile
Lena A Dixit
NPI 1174816433
$6,857.52
in general payments reported to CMS, 2019-2025
34 companies · $995 in 2025
The $995 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,041 · 2020: $434 · 2021: $697 · 2022: $1,104 · 2023: $900 · 2024: $687 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,540 · Honoraria: $25.59 · Gift: $15.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,540.36 |
| Honoraria | $25.59 |
| Gift | $15.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,036.86 | 2019-2025 | Clareon, Rocklatan, Tryptyr |
| Johnson & Johnson Surgical Vision, INC. | $749.40 | 2019-2025 | One Series Ultra, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $740.28 | 2020-2025 | Cequa |
| Ocular Therapeutix, INC. | $683.67 | 2019-2021 | |
| Abbvie INC. | $644.21 | 2022-2025 | Lumigan, Vuity, Alphagan P |
| Rxsight INC | $328.96 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $252.38 | 2019-2024 | |
| Allergan, INC. | $231.04 | 2019-2022 | |
| Harrow Eye, LLC | $229.02 | 2024-2025 | Vevye |
| Apellis Pharmaceuticals, INC. | $226.53 | 2022-2025 | Syfovre |
| Bausch & Lomb Americas INC. | $190.29 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Astellas Pharma US INC | $152.33 | 2025 | Izervay |
| Horizon Therapeutics Plc | $124.40 | 2022 | |
| Aerie Pharmaceuticals, INC. | $123.08 | 2019-2021 | |
| Optovue, INC. | $100.00 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $98.71 | 2019-2023 | |
| Carl Zeiss Meditec USA, INC. | $97.76 | 2021-2023 | Forum |
| Genentech USA, INC. | $94.46 | 2023-2024 | Vabysmo |
| Dompe US, INC. | $93.24 | 2019-2025 | Oxervate |
| Oyster Point Pharma, INC. | $92.98 | 2022-2025 | Tyrvaya, Ryzumvi |
| Regeneron Healthcare Solutions, INC. | $81.96 | 2023-2025 | Eylea Hd |
| Shire North American Group INC | $73.86 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $70.21 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $59.79 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $48.26 | 2019-2021 | |
| Iridex Corporation | $45.63 | 2022 | |
| Sight Sciences, INC. | $44.27 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $25.31 | 2023 | Rayone Emv, Omidria, Rayone Aspheric |
| Beaver-Visitec International, INC. | $24.06 | 2022 | |
| Optos, INC. | $22.81 | 2021 | |
| Omeros Corporation | $19.87 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $18.73 | 2022 | |
| Kala Pharmaceuticals, INC. | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lena Dixit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.